Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) CEO Gina Boswell purchased 6,000 shares of the business's stock in a transaction on Wednesday, October 9th. The shares were acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Bath & Body Works stock traded up $0.21 during midday trading on Friday, reaching $31.43. The stock had a trading volume of 4,838,512 shares, compared to its average volume of 3,699,097. The firm has a market capitalization of $6.89 billion, a PE ratio of 7.61, a P/E/G ratio of 0.94 and a beta of 1.77. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The firm's 50-day moving average price is $30.92 and its 200 day moving average price is $39.29.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.54 billion. Equities research analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.55%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works's dividend payout ratio (DPR) is presently 19.37%.
A number of equities analysts have recently weighed in on BBWI shares. Morgan Stanley lowered their target price on Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating on the stock in a research report on Thursday, September 5th. JPMorgan Chase & Co. lowered their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a "neutral" rating on the stock in a report on Thursday, August 29th. Evercore ISI reduced their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating for the company in a report on Wednesday, August 28th. Piper Sandler lowered their target price on shares of Bath & Body Works from $47.00 to $39.00 and set a "neutral" rating on the stock in a report on Thursday, July 11th. Finally, Robert W. Baird dropped their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a research report on Thursday, August 29th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Bath & Body Works presently has an average rating of "Moderate Buy" and a consensus price target of $42.35.
View Our Latest Research Report on Bath & Body Works
Several hedge funds and other institutional investors have recently modified their holdings of BBWI. Anomaly Capital Management LP bought a new position in Bath & Body Works in the 2nd quarter valued at $113,995,000. Lone Pine Capital LLC boosted its stake in Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company's stock valued at $441,871,000 after buying an additional 1,547,399 shares during the period. Vanguard Group Inc. grew its position in Bath & Body Works by 4.2% during the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company's stock worth $1,370,458,000 after buying an additional 1,102,124 shares in the last quarter. Interval Partners LP raised its holdings in shares of Bath & Body Works by 230.0% in the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company's stock valued at $50,007,000 after acquiring an additional 892,488 shares in the last quarter. Finally, Ceredex Value Advisors LLC bought a new stake in shares of Bath & Body Works during the 2nd quarter valued at about $25,867,000. 95.14% of the stock is currently owned by institutional investors.
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.